Anti-Aging Peptide Stack: NAD+, Ipamorelin, and MOTS-C for Longevity Research

Why Researchers Are Stacking NAD+, Ipamorelin, and MOTS-c for Anti-Aging Protocols

The search for compounds that may slow biological aging has accelerated dramatically over the past decade. Among the most exciting areas of longevity research is the strategic combination of NAD+ precursors, growth hormone secretagogues like Ipamorelin, and mitochondria-derived peptides such as MOTS-c. Together, these three compounds target aging through complementary — and potentially synergistic — mechanisms at the cellular level.

This guide breaks down the science behind each compound, explores how they may work together, and outlines what current research suggests about their roles in longevity biology.

The Three Pillars of This Anti-Aging Stack

NAD+: The Cellular Energy Currency

Nicotinamide adenine dinucleotide (NAD+) is a coenzyme found in every living cell. It plays a central role in energy metabolism, DNA repair, and the activation of sirtuins — a family of proteins strongly linked to longevity and cellular stress response. Research suggests that NAD+ levels decline significantly with age, dropping by as much as 50% between young adulthood and middle age.

A 2020 review published in Cell Metabolism highlighted NAD+ replenishment as a promising strategy in aging research, noting its potential to support mitochondrial function, reduce oxidative stress markers, and activate SIRT1 and SIRT3 pathways. Studies in animal models indicate that restoring NAD+ levels may support metabolic flexibility and cellular resilience.

• Primary mechanisms: Sirtuin activation, mitochondrial bioenergetics, DNA repair signaling
• Research half-life context: NAD+ itself is rapidly metabolized; precursors like NMN and NR are commonly used in research protocols
• Key research area: Aging, metabolic health, neurological function

Ipamorelin: A Selective Growth Hormone Secretagogue

Ipamorelin is a synthetic pentapeptide (Aib-His-D-2-Nal-D-Phe-Lys-NH2) that selectively stimulates the release of growth hormone (GH) from the pituitary gland by acting on the ghrelin receptor (GHSR-1a). Unlike older GH secretagogues, Ipamorelin is notable for its high selectivity — studies indicate it does not significantly stimulate cortisol, prolactin, or ACTH release at research-relevant doses.

Growth hormone naturally declines with age — a phenomenon sometimes called somatopause. Research suggests that supporting GH pulsatility through selective secretagogues like Ipamorelin may be associated with improvements in lean body composition, recovery markers, and sleep architecture in animal and early human research models. A study in Growth Hormone and IGF Research noted that Ipamorelin produced robust GH pulses with a favorable selectivity profile compared to earlier compounds in its class.

• Amino acid sequence: Aib-His-D-2-Nal-D-Phe-Lys-NH2
• Half-life: Approximately 2 hours in research models
• Key research area: GH axis support, body composition, sleep quality markers

MOTS-c: The Mitochondrial Longevity Peptide

MOTS-c (Mitochondrial Open Reading Frame of the 12S rRNA-c) is a relatively recent discovery in longevity science. Unlike most peptides, MOTS-c is encoded directly within mitochondrial DNA — specifically within the 12S rRNA gene — making it unique among known peptides. Research suggests it functions as a mitochondria-to-nucleus signaling molecule, regulating nuclear gene expression in response to metabolic stress.

A landmark 2021 study published in Nature Aging found that MOTS-c levels decline with age in humans and that exogenous MOTS-c administration in aged mouse models may support physical performance, insulin sensitivity, and inflammatory balance. Its 16-amino-acid sequence (MRWQEMGYIFYPRKLR) is conserved across mammals, underscoring its biological significance. Researchers have proposed that MOTS-c may act as a key regulator of the integrated stress response (ISR), a cellular pathway central to aging biology.

• Amino acid sequence: MRWQEMGYIFYPRKLR (16 AA)
• Half-life: Approximately 5-6 hours in murine models
• Key research area: Mitochondrial signaling, metabolic resilience, longevity pathways

How These Three Compounds May Work Synergistically

The rationale for combining NAD+, Ipamorelin, and MOTS-c lies in their complementary and non-overlapping mechanisms. Rather than hitting the same pathway redundantly, each compound addresses a distinct dimension of cellular aging.

NAD+ provides the foundational energy substrate and sirtuin activation needed for robust cellular maintenance. MOTS-c operates at the mitochondrial-nuclear communication axis, potentially amplifying the mitochondrial benefits that NAD+ supports. Ipamorelin, meanwhile, addresses the age-related decline in the GH axis — a systemic hormonal shift that affects tissue repair, fat metabolism, and recovery capacity.

Research in aging biology increasingly emphasizes that longevity is a multi-pathway challenge. A 2022 commentary in Aging Cell noted that targeting complementary hallmarks of aging simultaneously — including mitochondrial dysfunction, altered intercellular communication, and deregulated nutrient sensing — may produce more meaningful outcomes than single-target approaches.

Research Protocol Considerations

The following reflects general information from published research literature and is intended strictly for educational purposes for research professionals. This is not a dosing recommendation.

• NAD+ precursors (NMN/NR): Most research protocols study oral administration; some investigate subcutaneous delivery of NAD+ directly. Research doses in published studies range widely by model and endpoint.
• Ipamorelin: In research settings, subcutaneous administration is most commonly studied, typically evaluated in pulsatile patterns to mirror natural GH release rhythms.
• MOTS-c: Current research primarily involves subcutaneous administration in murine models. Human pharmacokinetic data is still emerging.

Researchers studying this stack should review the primary literature carefully and consider how each compound interacts with the specific biological model being investigated.

What the Research Landscape Looks Like in 2024

Interest in this combination stack has grown significantly among longevity researchers and biohackers. NAD+ biology remains one of the most actively published areas in aging science, with hundreds of peer-reviewed papers appearing annually. MOTS-c is newer but has generated significant excitement following its discovery by Dr. Pinchas Cohen and colleagues at USC, with ongoing investigation into its role in human aging. Ipamorelin continues to be studied for its clean selectivity profile relative to other GH secretagogues.

Together, these compounds represent three distinct but interconnected nodes in the biology of aging — energy metabolism, mitochondrial signaling, and endocrine support — making this combination a compelling subject for researchers exploring multi-target longevity strategies.

Explore Research-Grade Compounds at Maxx Laboratories

At Maxx Laboratories, we supply research-grade peptides and compounds with rigorous HPLC purity verification and third-party testing. Our NAD+, Ipamorelin, and MOTS-c are manufactured to research standards and intended exclusively for laboratory and research use.

Ipamorelin | Mots C | Nad Plus

Disclaimer: All products sold by Maxx Laboratories are intended for research purposes only. They are not intended for human consumption, and are not intended to assessed, treat, prevent, or mitigate any disease or health condition. All research must be conducted by qualified professionals in appropriate laboratory settings. Always consult a licensed healthcare provider before beginning any health-related protocol.